• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problem Material Too Rigid or Stiff (1544)
Patient Problems High Blood Pressure/ Hypertension (1908); Stenosis (2263)
Event Date 03/16/2017
Event Type  Injury  
Manufacturer Narrative
The device was received on mar 30, 2017.Gross examination was completed.The returned prosthesis was received blood stained.The visual inspections was performed on the returned prosthesis and confirmed the absence of manufacturing defects.
 
Event Description
After implanting perceval m, the valve was not symmetric and was not perfectly situated in the annulus.In this moment of the operation it was not clear if the problem was caused by the anatomy of the patient or of a dysfunction of the device.To be careful it was decided to take the valve out and use a stented valve with the same size.Everything went perfectly.Extra cross-clamp time of 100 minutes was needed.Ecc time of 120 min was needed.The device was replaced with a 21 mm sjm trifecta glide bioclave: model: tfgt-21a, implanted supra-ring.
 
Manufacturer Narrative
The partial manufacturing and material records for the perceval heart valve, model #icv1209, s/n # (b)(4) were pulled and reviewed by quality control at livanova (b)(4).The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1209) perceval heart valve at the time of manufacture and release.Review of the images taken during the steady-flow test confirmed that perceval valve sn #(b)(4) met all functional inspection criteria.A p-np gauge test confirmed the absence of dimensional irregularity.Simulation of the valve deployment, performed with the returned device, was not able to replicate the anomalous behavior reported in the initial incident narrative.Based on the performed analyses, the reported event cannot be explained by any factor intrinsic to the involved device.As reported by the customer, two different attempts were made to implant the valve and in both cases the perceval valve slipped at the level of the rca ostium, leading to mal-positioning of the valve.It is possible that the particular patient annulus anatomy did not allow for proper valve implantation.It should be noted that, based on the current ifu for the perceval valve, only one attempt to implant the valve can be made.If this attempt is unsuccessful, the perceval should not be re-implanted.
 
Event Description
After implanting perceval m, the valve was not symmetric and was not perfectly situated in the annulus.In this moment of the operation it was not clear if the problem was caused by the anatomy of the patient or of a dysfunction of the device.To be careful it was decided to take the valve out and use a stented valve with the same size.Everything went perfectly.Extra cross-clamp time of 100 minutes was needed.Ecc time of 120 min was needed.The device was replaced with a 21 mm sjm trifecta glide bioclave: model: tfgt-21a implanted supra-ring.Additional information: the perceval valve was conventionally implanted intra-annularly, but slipped twice at the same site (rca ostium).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
LIVANOVA CANADA CORP.
5005 fraser north way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 fraser north way
burnaby, bc 
MDR Report Key6505359
MDR Text Key73217622
Report Number3004478276-2017-00062
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)200629
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/19/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date06/29/2020
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/30/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/05/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/29/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient Weight65
-
-